Loading...
Azithromycin for COVID-19: Evidence review of the clinical benefit and harm
Blockman, M Cohen, K De Waal, R Gray, A Kredo, T Maartens, G Nel, J Parrish, A Rees, H Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Maartens, G
Nel, J
Parrish, A
Rees, H
Reubenson, G
Citations
Altmetric:
Abstract
Description
Azithromycin is used to treat certain bacterial infections, such as bronchitis; pneumonia; sexually transmitted diseases (STD); and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.
Date
2020-05-11
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Files
Research Projects
Organizational Units
Journal Issue
Keywords
Macrolide antibiotic, Drugs and supplements, SARS-CoV-2, Zithromax, Pharmacokinetics, Pharmacology, Azithromycin, Antibiotic, COVID-19
Citation
Blockman M, Cohen K, De Waal R, Gray A, et al. Azithromycin for COVID-19: evidence review of the clinical benefit and harm. South African National Department of Health, 2020.
License
Attribution 3.0 United States